Nutlin-3 Enhances Sorafenib Efficacy in Renal Cell Carcinoma

The renal cell carcinoma (RCC) is one of the top ten cancers in USA. The renal tumors are highly angiogenic and are resistant to conventional interventions, particularly radiotherapy. The advent of multispecific tyrosine kinase inhibitor sorafenib has improved the progression-free survival in RCC, b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vatsyayan, Rit, Singhal, Jyotsana, Nagaprashantha, Lokesh Dalasanur, Awasthi, Sanjay, Singhal, Sharad S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153352/
https://ncbi.nlm.nih.gov/pubmed/22006587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.20875
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge